Cover Image
市場調查報告書

美國的心臟節奏管理、電生理學、切除設備市場

US Market for Cardiac Rhythm Management Devices (2011-2021)

出版商 iData Research Inc. 商品編碼 129333
出版日期 內容資訊 英文 156 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的心臟節奏管理、電生理學、切除設備市場 US Market for Cardiac Rhythm Management Devices (2011-2021)
出版日期: 2015年09月01日 內容資訊: 英文 156 Pages
簡介

本報告提供該市場趨勢、各設備收益預測、銷售台數、平均銷售價格,以及製造商的市場佔有率和產品系列的競爭分析,為您概述為以下內容。

第1章 摘要整理

第2章 調查手法

第3章 美國的心臟節奏管理市場概要

  • 簡介
  • 市場概要
  • 趨勢分析
  • 推動市場成長要素和阻礙要素
  • 競爭分析
  • 合併、收購

第4章 心律調節器市場

  • 簡介
  • 市場概要
  • 市場分析、預測
  • 價格分析
  • 市場成長推動因素以及阻礙因素
  • 競爭分析

第5章 置入式除顫器市場

  • 簡介
  • 市場概要
  • 市場分析、預測
  • 市場成長推動因素以及阻礙因素
  • 競爭分析

第6章 心臟再同步用設備

  • 簡介
  • 市場概要
  • 市場分析、預測
  • 市場成長推動因素以及阻礙因素
  • 競爭分析

第7章 心臟領導

  • 簡介
  • 市場概要
  • 市場分析、預測
  • 市場成長推動因素以及阻礙因素
  • 競爭分析

第8章 附錄:穿戴式心臟去顫器市場

  • 簡介
  • 市場概要
  • 市場分析

第9章 簡稱

第10章 過程編碼

  • 編碼一覽

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_USCRM15_RPT

This report on cardiac rhythm management (CRM) devices analyzes the U.S. market for medical devices used for treating cardiac arrhythmias. The medical device markets included in this report are: implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads and wearable defibrillators.

Heart failure affects over five million people annually in the U.S., and is the most costly cardiovascular illness with upwards of $30 billion spent on managing heart failure each year. Cardiac rhythm management devices such as pacemakers, ICDs and CRT devices are implanted in patients with arrhythmias to correct cardiac pacing and/or to restart the heart after a sudden cardiac event. Sudden cardiac arrest (SCA) is one of the leading causes of death in the U.S., and is responsible for over 300,000 deaths annually. The chance of survival increases if defibrillation is delivered to the patient within ten minutes of the SCA event.

The competitive analysis outlines Medtronic as the main market leader, well above the top competitors like St. Jude Medical, Boston Scientific, Biotronik, Sorin, and many others.

**Noteworthy Insight: “The CRM market is expected to experience growth across all product segments over the forecast period. The more recent products are expected to experience strong growth on a percentage basis but not on an absolute unit or market growth basis simply because newer devices take a while for physicians to adopt. Also, considering the criticality of the procedures, it will take years of practice before a device can fully take off.“

This 156 Page Report Includes:

  • In-depth, professionally researched data that has been formatted and analyzed to gain actionable insights as quickly as possible
  • Executive summary on the US Market for Cardiac Rhythm Management
  • Trend Analysis by Segment
  • Market Value Forecasts until 2021 and History Back to 2011
  • Market Drivers and Limiters
  • Detailed Competitive Analysis for Each Market and Segment

To Get The Most Out Of This Report:

Combine it with our other European report on the Markets for Cardiac Rhythm Management to get a global picture of this entire market. The cardiac rhythm management (CRM) market includes pacemakers, cardiac resynchronization therapy (CRT) devices, implantable cardioverter defibrillators (ICDs) and cardiac stimulation leads. Over the forecast period, the CRM market will be driven by the aging population and adoption of advanced CRM devices. In the newer markets, particularly leadless pacemakers and subcutaneous ICDs (S-ICDs), continued education is critical to increase cardiologists' confidence in these types of cardiac devices. Most importantly, since the CRM market is dominated by large players and is quite a mature market, the responsibility lies on the market leaders to convince physicians that new device functionalities are required to improve the overall effectiveness of cardiac procedures.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. U.S. CARDIAC RHYTHM MANAGEMENT MARKET
  • 1.2. TREND ANALYSIS
  • 1.3. PACEMAKER MARKET
  • 1.4. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET
  • 1.5. CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET
  • 1.6. CARDIAC LEAD MARKET
  • 1.7. COMPETITIVE ANALYSIS
  • 1.8. LIST OF PROCEDURAL CODES

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

U.S. CARDIAC RHYTHM MANAGEMENT MARKET OVERVIEW

  • 3.1. INTRODUCTION
  • 3.2. MARKET OVERVIEW
  • 3.3. TREND ANALYSIS
  • 3.4. DRIVERS AND LIMITERS
    • 3.4.1. Market Drivers
    • 3.4.2. Market Limiters
  • 3.5. COMPETITIVE ANALYSIS
  • 3.6. MERGERS AND ACQUISITIONS

PACEMAKER MARKET

  • 4.1. INTRODUCTION
    • 4.1.1. Single and Dual Chamber Devices
    • 4.1.2. New Technologies
    • 4.1.3. Initial Placement and Replacement of Pacemakers
  • 4.2. MARKET OVERVIEW
  • 4.3. MARKET ANALYSIS AND FORECAST
    • 4.3.1. Total Pacemaker Market
    • 4.3.2. Total Single-Chamber Pacemaker Market
      • 4.3.2.1. Initial Placement Single-Chamber Pacemaker Market
      • 4.3.2.2. Replacement Single-Chamber Pacemaker Market
    • 4.3.3. Total Dual-Chamber Pacemaker Market
      • 4.3.3.1. Initial Placement Dual-Chamber Pacemaker Market
      • 4.3.3.2. Replacement Dual-Chamber Pacemaker Market
    • 4.3.4. Leadless Pacemaker Market
  • 4.4. PRICE ANALYSIS
  • 4.5. DRIVERS AND LIMITERS
    • 4.5.1. Market Drivers
    • 4.5.2. Market Limiters
  • 4.6. COMPETITIVE ANALYSIS

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET

  • 5.1. INTRODUCTION
    • 5.1.1. Cardiac Resynchronization Therapy-Defibrillators
  • 5.2. MARKET OVERVIEW
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Total ICD Market
    • 5.3.2. Total Single-Chamber ICD Market
      • 5.3.2.1. Initial Placement Single-Chamber ICD Market
      • 5.3.2.2. Replacement Single-Chamber ICD Market
    • 5.3.3. Total Dual-Chamber ICD Market
      • 5.3.3.1. Initial Placement Dual-Chamber ICD Market
      • 5.3.3.2. Replacement Dual-Chamber ICD Market
    • 5.3.4. S-ICD Market
  • 5.4. DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET

  • 6.1. INTRODUCTION
    • 6.1.1. Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
    • 6.1.2. Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
  • 6.2. MARKET OVERVIEW
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Total CRT Market
    • 6.3.2. Total CRT-P Market
      • 6.3.2.1. Initial Placement CRT-P Market
      • 6.3.2.2. Replacement CRT-P Market
    • 6.3.3. Total CRT-D Market
      • 6.3.3.1. Initial Placement CRT-D Market
      • 6.3.3.2. Replacement CRT-D Market
  • 6.4. DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE ANALYSIS

CARDIAC LEAD MARKET

  • 7.1. INTRODUCTION
    • 7.1.1. Replacement of Leads
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1. Total Cardiac Lead Market
    • 7.3.2. Pacing Lead Market
    • 7.3.3. Defibrillation Lead Market
    • 7.3.4. LV Lead Market
  • 7.4. DRIVERS AND LIMITERS
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. COMPETITIVE ANALYSIS

APPENDIX: WEARABLE DEFIBRILLATOR DEVICE MARKET

  • 8.1. INTRODUCTION
  • 8.2. MARKET ANALYSIS

ABBREVIATIONS

PROCEDURAL CODES

  • 10.1. LIST OF PROCEDURAL CODES
Back to Top